IDO1 and atherosclerosis: Eicosapentaenoic acid administration stimulates IDO-1 expression and reduces vascular inflammation and atherosclerosis in Ldlr−/− mice, possibly by decreasing the numbers of macrophages, dendritic and T cells [182].